Details of the Drug
General Information of Drug (ID: DMLN280)
| Drug Name |
RQ-00000010
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CJ-033466; PF-01354082; RQ-10; 5-HT 4 receptor partial agonist (GERD), RaQualia; 5-HT4 receptor partial agonist (gastric motility disorder), Pfizer; 5-hydroxytryptamine 4 receptor partial agonist (gastric motility disorder), Pfizer; 5-hydroxytryptamine 4 receptor partial agonist (gastroesophageal reflux), RaQualia
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure | 3D Structure is Not Available |
![]() |
|||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Gastric motility disorder | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | DA21 | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


